Related Experiment Video
Updated: Aug 22, 2025

Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions
Published on: November 12, 2017
Effects of Caffeine, a DNA Damage Response Inhibitor, on Papillomavirus Genome Replication
Sriramana Kanginakudru1, Timra Gilson1, Leny Jose1
1Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Abstract:
Epidemiological studies have revealed that caffeinated coffee imparts a reduced risk of oropharyngeal cancer, of which human papillomavirus (HPV) is one of the causative agents. Caffeine is a known inhibitor of the DNA damage response (DDR) pathway. We sought to test the effects of caffeine on the early replication of the HPV31 virus. It has been reported that the inhibition of several factors necessary for the DDR during the differentiation-dependent stage of HPV block genome amplification, while the HPV genome maintenance replication was unaffected. We first studied the effects of caffeine in the earliest stages of viral infection. Using pseudo-virions (PsV) expressing an m-Cherry reporter gene and quasi-virions (QsV) containing HPV31 genomes to mediate the infection, we found no evidence that caffeine impeded the viral entry; however, the infected cells displayed a reduced HPV copy number. In contrast, caffeine exposure increased the copy number of HPV31 episomes in the transient transfection assays and in the CIN612E cells that stably maintain viral episomes. There was a concomitant increase in the steady state levels of the HPV31 E1 and E2 transcripts, along with increased E2 loading at the viral origin of replication (ori). These results suggest that the caffeine-mediated inhibition of the DDR reduces viral genome replication in the early stage of infection, in contrast to the maintenance stage, in which the inhibition of the DDR may lead to an increase in viral amplicon replication.
Insights
Caffeine inhibits early human papillomavirus (HPV) replication by interfering with the DNA damage response (DDR). However, caffeine increases HPV DNA copy numbers during the viral genome maintenance stage.
Area of Science:
- Virology
- Molecular Biology
- Cancer Research
Background:
- Epidemiological studies link caffeinated coffee consumption to reduced oropharyngeal cancer risk.
- Human papillomavirus (HPV) is a causative agent in oropharyngeal cancer.
- Caffeine is known to inhibit the DNA damage response (DDR) pathway.
Purpose of the Study:
- To investigate the effects of caffeine on the early replication stages of HPV31.
- To determine if caffeine impacts viral entry and initial genome amplification.
- To explore caffeine's influence on HPV genome maintenance replication.
Main Methods:
- Utilized pseudo-virions (PsV) and quasi-virions (QsV) for HPV31 infection studies.
- Assessed viral entry and HPV DNA copy number in caffeine-treated cells.
- Performed transient transfection and stable cell line assays (CIN612E) with caffeine exposure.
- Analyzed HPV31 E1 and E2 transcript levels and E2 protein binding to the viral origin of replication (ori).
Main Results:
- Caffeine did not impede HPV31 viral entry.
- Caffeine treatment led to a reduced HPV copy number in early infection stages.
- Caffeine exposure increased HPV31 episome copy number in transfection and stable cell lines.
- Increased steady-state levels of HPV31 E1 and E2 transcripts and enhanced E2 loading at the viral ori were observed with caffeine.
Conclusions:
- Caffeine-mediated inhibition of the DDR pathway reduces early-stage HPV genome replication.
- Inhibition of the DDR by caffeine may enhance viral amplicon replication during the HPV genome maintenance stage.
- These findings suggest a differential effect of caffeine on HPV replication dynamics depending on the viral life cycle stage.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Viral Mutations
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
DNA Damage can Stall the Cell Cycle
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Inhibition of Cdk Activity